Suppr超能文献

COVID-19 气管切开术结局的系统评价和荟萃分析。

Tracheostomy outcomes in coronavirus disease 2019: a systematic review and meta-analysis.

机构信息

All India Institute of Medical Sciences, Jodhpur, India.

出版信息

Anaesthesiol Intensive Ther. 2021;53(5):418-428. doi: 10.5114/ait.2021.111594.

Abstract

Tracheostomy is a standard surgical procedure that is used in critically ill patients who require sustained mechanical ventilation. In this article, we review the outcomes of coronavirus disease 2019 (COVID-19) patients who underwent tracheostomy. We searched for relevant articles on PubMed, Scopus, and Google Scholar, up to April 20, 2021. This meta- analysis examines ventilation liberation, decannulation, and hospital mortality rates in COVID-19 patients who have undergone tracheostomy. Two investigators evaluated the articles, and the differences of opinion were settled by consensus with a third author. A total of 4366 patients were included in 47 related articles for this meta-analysis. After data pooling, the proportions of ventilation liberation, decannulation and mortality were found to be 48% (95% CI: 31-64), 42% (95% CI: 17-69) and 18% (95% CI: 9-28) respectively. The Luis Furuya-Kanamori (LFK) index values for ventilation liberation, decannulation and mortality were 4.28, 1.32 and 0.69. No transmission of the disease attributable to participating in tracheostomy procedures was reported in most of the included articles.

摘要

气管切开术是一种标准的外科手术,用于需要持续机械通气的危重症患者。本文回顾了接受气管切开术的 2019 冠状病毒病(COVID-19)患者的结局。我们在 PubMed、Scopus 和 Google Scholar 上搜索了截至 2021 年 4 月 20 日的相关文章。这项荟萃分析检查了 COVID-19 患者接受气管切开术的通气撤离、拔管和住院死亡率。两名调查员评估了这些文章,意见分歧通过第三名作者的共识解决。共有 47 篇相关文章纳入了 4366 例患者进行荟萃分析。数据汇总后,通气撤离、拔管和死亡率的比例分别为 48%(95%CI:31-64)、42%(95%CI:17-69)和 18%(95%CI:9-28)。通气撤离、拔管和死亡率的 Luis Furuya-Kanamori(LFK)指数值分别为 4.28、1.32 和 0.69。在大多数纳入的文章中,没有报告与参与气管切开术相关的疾病传播。

相似文献

4
Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients.COVID-19 患者气管切开术结局的系统评价和荟萃分析。
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1013-1023. doi: 10.1016/j.bjoms.2021.05.011. Epub 2021 May 18.
6
Systemic corticosteroids for the treatment of COVID-19.全身性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.
7
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
10
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.

本文引用的文献

2
Long-term Outcomes After Tracheostomy for COVID-19.COVID-19患者气管切开术后的长期预后
Arch Bronconeumol. 2021 Apr;57:54-56. doi: 10.1016/j.arbres.2021.01.014. Epub 2021 Feb 2.
5
Surgical tracheostomy in a cohort of COVID-19 patients.COVID-19 患者的外科气管切开术。
HNO. 2021 Apr;69(4):303-311. doi: 10.1007/s00106-021-01021-4. Epub 2021 Mar 5.
8
Tracheostomy in Covid-19 Patients: Surgical Concerns and Considerations.新冠肺炎患者的气管切开术:手术要点与注意事项
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2862-2865. doi: 10.1007/s12070-021-02383-5. Epub 2021 Jan 29.
10
Surgical Tracheostomy Outcomes in COVID-19-Positive Patients.新冠病毒检测呈阳性患者的外科气管切开术结果
OTO Open. 2021 Jan 8;5(1):2473974X20984998. doi: 10.1177/2473974X20984998. eCollection 2021 Jan-Mar.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验